Stem cells and growth factor delivery systems for cardiovascular disease

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Cardiovascular Biology

Background:

• Coronary artery disease (CAD) and peripheral artery disease (PAD) are leading causes of death, affecting millions globally.
• Current treatments like medication, bypass surgery, and angioplasty have limitations in tissue repair and regeneration.
• Stem cell and tissue engineering offer promising avenues for enhancing natural healing processes in ischemic tissues.

Purpose of the Study:

• To review the potential of combining stem cells, biomaterials, and growth factors for cardiovascular regeneration.
• To explore novel delivery systems for stem cells and growth factors to improve therapeutic efficacy.
• To discuss strategies for promoting angiogenesis and reperfusion in ischemic tissues.

Main Methods:

• Review of existing literature on stem cell therapy, biomaterials, and growth factor delivery systems.
• Discussion of vehicle-based delivery strategies and cell-based gene therapy.
• Analysis of how combined approaches stimulate resident and exogenous stem cells.

Main Results:

• Combining stem cells, biomaterials, and growth factors can enhance cell therapy efficacy.
• Biocompatible polymers can support stem cell and growth factor maintenance in damaged tissue.
• Delivery systems can recruit and direct stem cells, improving angiogenesis and reperfusion.

Conclusions:

• Integrated stem cell and tissue engineering strategies hold significant potential for regenerating ischemic tissues in CAD and PAD.
• Novel delivery systems, including vehicle-based and gene therapy approaches, are crucial for successful regeneration.
• These approaches can promote the healing of damaged cardiovascular tissues by stimulating resident and exogenous stem cells.